DDS
NEUTRAL
$595.2
Live
Dillard's, Inc. · NYSE
Target $519.67
(-12.7%)
$330.0
52W Range
$741.98
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 26, 2026
Market cap
$9.3B
P/E
16.34
ROE
31.9%
Profit margin
8.7%
Debt/Equity
0.31
Dividend yield
0.2%
AI Analysis
AI-powered fundamental assessment
Confidence
85%
DDS exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.31. However, the stock is significantly overvalued, trading at $595.20—nearly double its Graham Number ($305.57) and Intrinsic Value ($255.01). While profitability remains high with an ROE of 31.90%, the company is facing a growth stagnation with negative YoY revenue and earnings growth. The disconnect between strong fundamental health and poor valuation/growth metrics suggests a limited upside from current levels.
Key Strengths
Strong financial health (Piotroski F-Score 8/9)
Excellent Return on Equity (ROE) of 31.90%
Conservative leverage with Debt/Equity at 0.31
Strong liquidity position (Current Ratio 2.65)
Consistent history of beating earnings estimates
Key Risks
Severe overvaluation relative to Graham and Intrinsic values
Negative YoY revenue growth (-3.00%) and earnings growth (-3.10%)
Bearish technical trend (0/100)
High PEG ratio (2.24) indicating price exceeds growth potential
Current price is significantly above the analyst target price of $519.67
AI Fair Value Estimate
Based on comprehensive analysis
$310.0
-47.9% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
53
Moderate
25
35
90
95
20
AI Verdict
Fundamentally sound but overpriced
Key drivers: Piotroski F-Score, Graham Number vs Price, Negative Growth Rates, High ROE
Confidence
90%
Value
25/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 16.34 is moderate for the sector
Watchpoints
- Price is ~95% above Graham Number
- Price is ~133% above Intrinsic Value
- High Price/Book ratio of 5.23
Future
35/100
Ref Growth rates
Positives
- Consistent earnings surprises
Watchpoints
- Negative YoY Revenue Growth
- Negative YoY Earnings Growth
- High PEG ratio
Past
90/100
Ref Historical trends
Positives
- Massive 5Y price change (+708.6%)
- Strong track record of EPS beats over 25 quarters
Watchpoints
No urgent risks highlighted.
Health
95/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score 8/9
- Low Debt/Equity (0.31)
- Strong Current Ratio (2.65)
Watchpoints
No urgent risks highlighted.
Dividend
20/100
Ref Yield, Payout
Positives
- Very low payout ratio (3.02%)
Watchpoints
- Negligible dividend yield (0.20%)
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$595.2
Analyst Target
$519.67
Upside/Downside
-12.7%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for DDS and closest competitors.
Updated 2026-04-24
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
DDS
Dillard's, Inc.
Primary
|
+708.6% | +134.4% | +88.9% | +2.5% | +5.0% | -1.7% |
|
ALSN
Allison Transmission Holdings, Inc.
Peer
|
+163.1% | +161.4% | -7.9% | +23.3% | +8.7% | -0.6% |
|
ALV
Autoliv, Inc.
Peer
|
+62.6% | +63.5% | +28.6% | +8.9% | +5.9% | +0.4% |
|
BROS
Dutch Bros Inc.
Peer
|
+66.2% | +78.1% | +0.1% | +2.5% | -4.9% | -1.9% |
|
BWA
BorgWarner Inc.
Peer
|
+34.0% | +26.8% | +50.3% | +33.5% | +5.0% | +1.1% |
DDS
Dillard's, Inc.
Primary
5Y
+708.6%
3Y
+134.4%
1Y
+88.9%
6M
+2.5%
1M
+5.0%
1W
-1.7%
ALS
Allison Transmission Holdings, Inc.
Peer
5Y
+163.1%
3Y
+161.4%
1Y
-7.9%
6M
+23.3%
1M
+8.7%
1W
-0.6%
ALV
Autoliv, Inc.
Peer
5Y
+62.6%
3Y
+63.5%
1Y
+28.6%
6M
+8.9%
1M
+5.9%
1W
+0.4%
BRO
Dutch Bros Inc.
Peer
5Y
+66.2%
3Y
+78.1%
1Y
+0.1%
6M
+2.5%
1M
-4.9%
1W
-1.9%
BWA
BorgWarner Inc.
Peer
5Y
+34.0%
3Y
+26.8%
1Y
+50.3%
6M
+33.5%
1M
+5.0%
1W
+1.1%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
16.34
Forward P/E
18.26
PEG Ratio
2.24
P/B Ratio
5.23
P/S Ratio
1.42
EV/Revenue
1.34
EV/EBITDA
10.36
Market Cap
$9.3B
Profitability
Profit margins and return metrics
Profit Margin
8.69%
Operating Margin
10.13%
Gross Margin
40.32%
ROE
31.9%
ROA
11.88%
Growth
Revenue and earnings growth rates
Revenue Growth
-3.0%
Earnings Growth
-3.1%
Q/Q Revenue Growth
-3.03%
Q/Q Earnings Growth
-5.0%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.31
Low debt
Current Ratio
2.65
Strong
Quick Ratio
1.24
Good
Cash/Share
$68.7
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q1 2026
Revenue
$2.0B
Gross Margin
36.3%
Op. Margin
10.4%
Net Margin
10.2%
Total Assets
$3.5B
Liabilities
$1.7B
Equity
$1.8B
Debt/Equity
0.97x
Operating CF
$0.2B
CapEx
$-0.0B
Free Cash Flow
$0.2B
FCF Yield
91%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-14
$N/A
2026-02-24
$12.16
+33.1% surprise
2025-11-13
$8.29
+33.7% surprise
2025-08-14
$4.43
+34.2% surprise
Consumer Cyclical Sector Comparison
Comparing DDS against 353 companies in the Consumer Cyclical sector
(23 bullish, 111 neutral, 219 bearish)
P/E Ratio
16.34
This Stock
vs
34.01
Sector Avg
-52.0%
(Discount)
Return on Equity (ROE)
31.9%
This Stock
vs
-48.88%
Sector Avg
-165.3%
(Below Avg)
Profit Margin
8.69%
This Stock
vs
-6.31%
Sector Avg
-237.7%
(Weaker)
Debt to Equity
0.31
This Stock
vs
1.54
Sector Avg
-79.6%
(Less Debt)
Revenue Growth
-3.0%
This Stock
vs
30.61%
Sector Avg
-109.8%
(Slower)
Current Ratio
2.65
This Stock
vs
2.42
Sector Avg
+9.4%
(Better)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
DDS
Dillard's, Inc.
|
NEUTRAL | $9.3B | 16.34 | 31.9% | 8.7% | $595.2 | |
|
ALSN
Allison Transmission Holdings, Inc.
|
NEUTRAL | $9.16B | 13.63 | 40.4% | 22.8% | $109.57 | Compare |
|
ALV
Autoliv, Inc.
|
NEUTRAL | $9.75B | 13.03 | 31.0% | 7.1% | $126.94 | Compare |
|
BROS
Dutch Bros Inc.
|
NEUTRAL | $10.04B | 124.43 | 11.7% | 4.0% | $60.97 | Compare |
|
BWA
BorgWarner Inc.
|
BEARISH | $10.32B | 67.2 | 3.0% | 0.9% | $47.71 | Compare |
DDS
Dillard's, Inc.
NEUTRAL
Mkt Cap
$9.3B
P/E
16.3
ROE
31.9%
Price
$595.2
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-14 | WORLEY DEAN L | General Counsel | Gift | 100 | - |
| 2026-03-25 | FREEMAN JAMES I | Director | Gift | 75 | - |
| 2026-01-30 | LUCIE DENISE ALEXANDRA | Officer | Stock Award | 60 | $36,453 |
| 2026-01-30 | JAZIC ANNEMARIE | Officer | Stock Award | 61 | $37,061 |
| 2026-01-30 | STOCKMAN JAMES D | Officer | Stock Award | 55 | $33,415 |
| 2026-01-30 | WORLEY DEAN L | General Counsel | Stock Award | 73 | $44,351 |
| 2026-01-30 | JOHNSON CHRIS B | Officer | Stock Award | 87 | $52,857 |
| 2026-01-30 | LITCHFORD MIKE | Officer | Stock Award | 45 | $27,340 |
| 2026-01-30 | BOLIN TOM W | Officer | Stock Award | 42 | $25,517 |
| 2026-01-30 | DILLARD WILLIAM T II | Chief Executive Officer | Stock Award | 292 | $177,405 |
| 2026-01-30 | MUSGRAVE BRANT | Officer | Stock Award | 42 | $25,517 |
| 2026-01-30 | WATTS PHILLIP R | Officer | Stock Award | 87 | $52,857 |
| 2026-01-30 | MAHAFFY DENISE DILLARD | Officer and Director | Stock Award | 90 | $54,680 |
| 2026-01-30 | MATHENY DRUE | Officer and Director | Stock Award | 133 | $80,804 |
| 2026-01-30 | DILLARD MIKE | Officer and Director | Stock Award | 126 | $76,551 |
WORLEY DEAN L
General Counsel
2026-04-14
100 shares
FREEMAN JAMES I
Director
2026-03-25
75 shares
LUCIE DENISE ALEXANDRA
Officer
2026-01-30
60 shares
·
$36,453
JAZIC ANNEMARIE
Officer
2026-01-30
61 shares
·
$37,061
STOCKMAN JAMES D
Officer
2026-01-30
55 shares
·
$33,415
WORLEY DEAN L
General Counsel
2026-01-30
73 shares
·
$44,351
JOHNSON CHRIS B
Officer
2026-01-30
87 shares
·
$52,857
LITCHFORD MIKE
Officer
2026-01-30
45 shares
·
$27,340
BOLIN TOM W
Officer
2026-01-30
42 shares
·
$25,517
DILLARD WILLIAM T II
Chief Executive Officer
2026-01-30
292 shares
·
$177,405
MUSGRAVE BRANT
Officer
2026-01-30
42 shares
·
$25,517
WATTS PHILLIP R
Officer
2026-01-30
87 shares
·
$52,857
MAHAFFY DENISE DILLARD
Officer and Director
2026-01-30
90 shares
·
$54,680
MATHENY DRUE
Officer and Director
2026-01-30
133 shares
·
$80,804
DILLARD MIKE
Officer and Director
2026-01-30
126 shares
·
$76,551
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
NONE
3 analysts
Telsey Advisory Group
2026-02-25
Market Perform
Market Perform
JP Morgan
2026-02-25
Underweight
Underweight
UBS
2025-11-28
Sell
Sell
JP Morgan
2025-11-25
Underweight
Underweight
UBS
2025-11-05
Sell
Sell
Past News Coverage
Recent headlines mentioning DDS from our newsroom.
Newest → oldest
No matching news yet.